TG
Therapeutic Areas
InterCure Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Canndoc Product Portfolio | Chronic Pain, Chemotherapy-Induced Nausea & Vomiting, PTSD, Crohn's Disease, Parkinson's Disease, and other approved conditions | Approved |
Leadership Team at InterCure
A(
Alexander (Sasha) Rabinovich
Interim Chief Executive Officer and Director
AC
Amos Cohen
Chief Financial Officer
NB
Nissim Bracha
Chief Operating Officer
DY
Dr. Yaron Biala
Chief Medical Officer
PR
Prof. Raphael Mechoulam
Scientific Advisor / Honorary Director
D(
David (Dedi) Cohen
Director